Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-03-10 @ 11:50 PM
Study NCT ID:
NCT03478956
Status:
TERMINATED
Last Update Posted:
2024-12-27
First Post:
2018-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
Sponsor:
Hoffmann-La Roche
Organization: